TipRanks
Go Ultimate55% OFF

Royalty Pharma (RPRXN) Revenue

Royalty Pharma Revenue

Royalty Pharma had a revenue of 674.14M in the quarter ending Jun 30, 2026, with 6.91%. This bring the company's revenue in the last twelve months to 2.54B, Increased 3.91%. In the fiscal year ending Dec 31, 2025, Royalty Pharma had annual revenue of 2.38B with 5.06% growth.

Revenue (ttm)
2.54B
Revenue Growth
0.03%
P/S Ratio
305.97
Revenue/Employee
MXN 23,781,930
Employees
100
Market Cap
MXN 727.67B

Revenue Chart

Royalty Pharma Revenue - Annual

0500M1B1.5B2B2.5B1.60B1.79B1.81B2.12B2.29B2.24B2.35B2.26B2.38B201720182019202020212022202320242025
Revenue History
Download to Excel
MX:RPRXN revenue history
Fiscal End DateRevenueChangeGrowth
Dec 31, 20252.38B114.62M5.06%
Dec 31, 20242.26B-90.98M-3.86%
Dec 31, 20232.35B117.34M5.24%
Dec 31, 20222.24B-52.25M-2.28%
Dec 31, 20212.29B167.11M7.87%
Dec 31, 20202.12B308.10M16.98%
Dec 31, 20191.81B19.36M1.08%
Dec 31, 20181.79B196.96M12.33%
Dec 31, 20171.60B――
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Related stocks
CompanyRevenue
MX:RPRXN2.54B
CORT830.81M
PBH1.10B
SVA448.27M
KNSA945.96M
LQDA450.91M